Kymera Therapeutics Stock Forecast

Stock Price Forecast

The 19 analysts that cover Kymera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $69.58, which forecasts a 4.54% increase in the stock price over the next year. The lowest target is $52 and the highest is $90.

Price Target: $69.58 (+4.54%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$52	$69.58	$70	$90
Change	-21.88%	+4.54%	+5.17%	+35.22%

Analyst Ratings

The average analyst rating for Kymera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	7	7	7	8	9	10
Buy	7	7	7	8	9	9
Hold	2	2	2	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	17	18	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Srikripa Devarakonda Truist Securities	Truist Securities	Strong Buy Maintains $68 → $80	Strong Buy	Maintains	$68 → $80	+20.19%	Nov 26, 2025
Etzer Darout Barclays	Barclays	Buy Maintains $60 → $70	Buy	Maintains	$60 → $70	+5.17%	Nov 5, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $53 → $69	Buy	Maintains	$53 → $69	+3.67%	Nov 5, 2025
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $70 → $84	Strong Buy	Maintains	$70 → $84	+26.20%	Nov 5, 2025
Brad Canino Guggenheim	Guggenheim	Strong Buy Initiates $90	Strong Buy	Initiates	$90	+35.22%	Nov 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

56.87M

from 47.07M

20.81%

from 47.07M

Revenue Next Year

51.01M

from 56.87M

-10.31%

from 56.87M

EPS This Year

-3.54

from -2.98

EPS Next Year

-3.89

from -3.54

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	34.03M	72.83M	46.83M	78.59M	47.07M	56.87M	51.01M
Revenue Growth	1,059.99%	114.00%	-35.71%	67.84%	-40.11%	20.81%	-10.31%
EPS	-3.15	-2.09	-2.87	-2.52	-2.98	-3.54	-3.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	25	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	110.3M	105.0M
Avg	56.9M	51.0M
Low	38.2M	9.8M

Revenue Growth

Revenue Growth	2025	2026
High	134.2%	84.6%
Avg	20.8%	-10.3%
Low	-18.8%	-82.8%

EPS Forecast

EPS	2025	2026
High	-2.91	-3.14
Avg	-3.54	-3.89
Low	-3.78	-5.88

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.